Abstract
Aberrant glycosylation occurs during development of gastric carcinomas. The initiation of mucin‐type O‐glycosylation is regulated by GalNAc‐T3 (UDP‐N‐acetylgalactosamine:polypeptide N‐acetyl‐galactosaminyltransferase‐3). However, the clinical significance of GalNAc‐T3 expression in human gastric carcinoma has not yet been demonstrated. In the present study, we investigated the relationship between immunohistochemical GalNAc‐T3 expression and various clinicopathologic factors, including prognosis, in 117 gastric carcinoma patients. Of 117 gastric carcinomas examined, 59 (50.4%) showed strong expression of GalNAc‐T3. Strong expression was detected in 38 of 59 (64.4%) differentiated type and in 21 of 58 (36.2%) undifferentiated gastric carcinomas, indicating that the expression of GalNAc‐T3 correlated significantly with tumor differentiation (P=0.0023, x 2 test). Overall 5‐year survival rate in patients with strong GalNAc‐T3 expression (71.0%) was significantly better than that of patients with weak expression (49.3%) (P=0.0197, log‐rank test). Multivariate analysis identified GalNAc‐T3 expression as an independent prognostic factor (P=0.0158, Cox proportional hazards model). Our data suggest that GalNAc‐T3 expression may be a useful marker for prognosis and differentiation of gastric carcinomas. (Cancer Sci 2003; 94: 32–36)
References
- 1. Statistics and Information Department, Minister's Secretariat, Ministry of Health Vital Statistics 1998. Japan . Vol. 1 (in Japanese). Tokyo : Health and Statistics Association; 2000. p. 284–90. [Google Scholar]
- 2. Kuan SF, Byrd JC, Basbaum CB, Kim YS. Characterization of quantitative mucin variants from a human colon cancer cell line. Cancer Res 1987; 47: 5715–24. [PubMed] [Google Scholar]
- 3. Bresalier RS, Niv Y, Byrd JC, Duh QY, Toribara NW, Rockwell RW, Dahiya R, Kim YS. Mucin production by human colonic carcinoma cells correlates with their metastatic potential in animal models of colon cancer metastasis. J Clin Invest 1991; 87: 1037–45. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Ligtenberg MJ, Buijs F, Vos HL, Hilkens J. Suppression of cellular aggregation by high levels of episialin. Cancer Res 1992; 52: 2318–24. [PubMed] [Google Scholar]
- 5. Majuri ML, Mattila P, Renkonen, R. Recombinant E‐selectin‐protein mediates tumor cell adhesion via sialyl‐Le(a) and sialyl‐Le(x). Biochem. Biophys Res Commun 1992; 182: 1376–82. [DOI] [PubMed] [Google Scholar]
- 6. Kojima N, Handa K, Newman W, Hakomori S. Inhibition of selectin‐dependent tumor cell adhesion to endothelial cells and platelets by blocking O‐gly cosylation of these cells. Biochem. Biophys Res Commun 1992; 182: 1288–95. [DOI] [PubMed] [Google Scholar]
- 7. Hull SR, Bright A, Carraway KL, Abe M, Hayes DF, Kufe DW. Oligosac‐charide differences in the DF3 sialomucin antigen from normal human milk and the BT‐20 human breast carcinoma cell line. Cancer Commun 1989; 1: 261–7. [PubMed] [Google Scholar]
- 8. Ho SB, Kim YS. Carbohydrate antigens on cancer‐associated mucin‐like molecules. Semin Cancer Biol 1991; 2: 389–400. [PubMed] [Google Scholar]
- 9. Hagen KG, Bedi GS, Tetaert D, Kingsley PD, Hagen FK, Balys MM, Beres TM, Degand P, Tabak LA. Cloning and characterization of a ninth member of the UDP‐GalNAc:polypeptide N‐acetylgalactosaminyl‐transferase family, ppGaNTase‐T9. J Biol Chem 2001; 276: 17395–404. [DOI] [PubMed] [Google Scholar]
- 10. Clausen H, Bennett EP. A family of UDP‐GalNAc: polypeptide N‐acetylgalactosaminyl‐transferases control the initiation of mucin‐type O‐linked glycosylation. Glycobiology 1996; 6: 635–46. [DOI] [PubMed] [Google Scholar]
- 11. Nomoto M, Izumi H, Ise T, Kato K, Takano H, Nagatani G, Shibao K, Ohta R, Imamura T, Kuwano M, Matsuo K, Yamada Y, Itoh H, Kohno K. Structural basis for the regulation of UDP‐N‐acetyl‐alpha‐D‐galactosamine: polypeptide N‐acetylgalactosaminyl transferase‐3 gene expression in adenocarcinoma cells. Cancer Res 1999; 59: 6214–22. [PubMed] [Google Scholar]
- 12. Shibao K, Izumi H, Nakayama Y, Ohta R, Nagata N, Nomoto M, Matsuo K, Yamada Y, Kitazato K, Itoh H, Kohno K. Expression of UDP‐N‐acetyl‐alpha‐D‐galactosamine‐polypeptide GalNAc N‐acetylgalactosaminyl transferase‐3 in relation to differentiation and prognosis in patients with colorectal carcinoma. Cancer 2002; 94: 1939–46. [DOI] [PubMed] [Google Scholar]
- 13. Sobin LH, Wittekind CH. International Union Against Cancer. TNM classification of malignant tumors. 5th ed. New York : John Wiley & Sons, Inc; 1997. [Google Scholar]
- 14. Japanese Gastric Cancer Association . Japanese classification of gastric carcinoma. 13th ed. Tokyo : Kanehara & Co Ltd; 1999. [DOI] [PubMed] [Google Scholar]
- 15. Hsu SM, Raine L, Fanger H. The use of antiavidin antibody and avidin‐biotin‐peroxidase complex in immunoperoxidase technics. Am J Clin Pathol 1981; 75: 816–21. [DOI] [PubMed] [Google Scholar]
- 16. Sutherlin ME, Nishimori I, Caffrey T, Bennett EP, Hassan H, Mandel U, Mack D, Iwamura T, Clausen H, Hollingsworth MA. Expression of three UDP‐N‐acetyl‐alpha‐D‐galactosamine: polypeptide GalNAc N‐acetylgalactosaminyl‐transferases in adenocarcinoma cell lines. Cancer Res 1997; 57: 4744–8. [PubMed] [Google Scholar]
- 17. Kim YS, Gum J Jr, Brockhausen I. Mucin glycoproteins in neoplasia. Glycoconj J 1996; 13: 693–707. [DOI] [PubMed] [Google Scholar]
- 18. Lesuffleur T, Zweibaum A, Real FX. Mucins in normal and neoplastic human gastrointestinal tissues. Crit Rev Oncol Hematol 1994; 17: 153–80. [DOI] [PubMed] [Google Scholar]
- 19. Hakomori S. Aberrant glycosylation in tumors and tumor‐associated carbohydrate antigens. Adv Cancer Res 1989; 52: 257–331. [DOI] [PubMed] [Google Scholar]
- 20. Schirrmacher V. Cancer metastasis: experimental approaches, theoretical concepts, and impacts for treatment strategies. Adv Cancer Res 1985; 43: 1–73. [DOI] [PubMed] [Google Scholar]